These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38695786)

  • 1. Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect.
    Gärde M; Matheson GJ; Varnäs K; Svenningsson P; Hedman-Lagerlöf E; Lundberg J; Farde L; Tiger M
    Int J Neuropsychopharmacol; 2024 May; 27(5):. PubMed ID: 38695786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain.
    Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Bundgaard C; Bang-Andersen B; Sanchez C; Halldin C; Farde L; Finnema SJ
    Neuropsychopharmacology; 2019 Sep; 44(10):1706-1713. PubMed ID: 31216565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder.
    Tiger M; Rück C; Forsberg A; Varrone A; Lindefors N; Halldin C; Farde L; Lundberg J
    Psychiatry Res; 2014 Aug; 223(2):164-70. PubMed ID: 24916155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled PET study of ketamine´s effect on serotonin
    Tiger M; Veldman ER; Ekman CJ; Halldin C; Svenningsson P; Lundberg J
    Transl Psychiatry; 2020 Jun; 10(1):159. PubMed ID: 32475989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.
    Nord M; Finnema SJ; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1577-86. PubMed ID: 23351590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
    Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
    Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.
    Varnäs K; Nyberg S; Karlsson P; Pierson ME; Kågedal M; Cselényi Z; McCarthy D; Xiao A; Zhang M; Halldin C; Farde L
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):533-45. PubMed ID: 21234549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
    Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
    Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.
    Deen M; Hougaard A; Hansen HD; Schain M; Dyssegaard A; Knudsen GM; Ashina M
    JAMA Neurol; 2019 Jul; 76(7):834-840. PubMed ID: 31135819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT
    Tiger M; Varnäs K; Okubo Y; Lundberg J
    Psychopharmacology (Berl); 2018 May; 235(5):1317-1334. PubMed ID: 29546551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.
    Miller JM; Hesselgrave N; Ogden RT; Zanderigo F; Oquendo MA; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Nov; 74(10):760-7. PubMed ID: 23664414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.
    Finnema SJ; Varrone A; Hwang TJ; Gulyás B; Pierson ME; Halldin C; Farde L
    Synapse; 2010 Jul; 64(7):573-7. PubMed ID: 20222157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant medication exposure and 5-HT
    Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
    Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers.
    Varnäs K; Jučaite A; McCarthy DJ; Stenkrona P; Nord M; Halldin C; Farde L; Kanes S
    Cephalalgia; 2013 Jul; 33(10):853-60. PubMed ID: 23430984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
    Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest reliability of [11C]AZ10419369 binding to 5-HT(1B) receptors in human brain.
    Nord M; Finnema SJ; Schain M; Halldin C; Farde L
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):301-7. PubMed ID: 24006152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients.
    Varrone A; Svenningsson P; Marklund P; Fatouros-Bergman H; Forsberg A; Halldin C; Nilsson LG; Farde L
    Synapse; 2015 Jul; 69(7):365-74. PubMed ID: 25914348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.